Table 2

Distribution of the rheumatoid arthritis patients according to the presence of anti-MCV, anti-CCP, and IgM-RF

Anti-CCP-positive

(n = 80), number (percentage)

Anti-CCP-negative

(n = 76), number (percentage)



Cutoff 20 U/mL

Cutoff 28 U/mL

Cutoff 20 U/mL

Cutoff 28 U/mL


Anti-MCV

Positive

75 (93.75)

71 (88.75)

14 (18.4)

9 (11.8)

Negative

5 (6.25)

9 (11.25)

62 (81.6)

67 (88.2)

RF+

Anti-MCV+

65 (81.25)

61 (76.25)

5 (6.6)

3 (3.9)

Anti-MCV-

1 (3.75)

5 (6.25)

8 (10.5)

10 (13.2)

RF-

Anti-MCV+

10 (12.5)

10 (12.5)

9 (11.8)

6 (7.9)

Anti-MCV-

4 (5)

4 (5)

54 (71.1)

57 (75)


Anti-CCP, anti-cyclic citrullinated peptide antibody; anti-MCV, anti-mutated vimentin citrullinated antibody; RF, rheumatoid factor.

Nicaise Roland et al. Arthritis Research & Therapy 2008 10:R142   doi:10.1186/ar2570

Open Data